US Stock Market Move | U.S. company ALB.US rose by 3%, with institutions predicting a significant upward adjustment in mid-term earnings for 2026.

On Tuesday, the lithium industry giant Albemarle (ALB.US) rose by 3% to $174.42. Analyst Ben Isaacson from the Bank of Nova Scotia stated that concerns about Albemarle's balance sheet are gradually fading away - the company has achieved leverage optimization for the fourth consecutive quarter, and is expected to reach positive free cash flow of 3-4 billion USD by the end of 2025 through a combination of reducing operating expenses and capital expenditures. With increasing visibility of the industry turning point and continued progress of the company's self-rescue measures, the stock price is expected to see a significant increase. "Projected mid-2026 profits are expected to be significantly revised upward as confidence in the tightening lithium market data increases," he added. For many ordinary North American investors, Albemarle is the "only feasible large-cap stock available to express their views on lithium".